The global Diabetic Retinopathy (DR) Analysis Software market was valued at US$ 1207 million in 2023 and is anticipated to reach US$ 2045.2 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.

Diabetic Retinopathy (DR) Analysis Software Market

The software is artificial intelligence-based, composed of automated DR screening and mobile or hardware components. The goal is to bring long term and cheap diabetic retinopathy screening to diabetic patients through ML or mobile phones. The core technique for the analysis is deep learning module, and with the web interfaces, both doctors and patients could visually understand the results.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Diabetic Retinopathy (DR) Analysis Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Retinopathy (DR) Analysis Software.

Report Scope

The Diabetic Retinopathy (DR) Analysis Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Retinopathy (DR) Analysis Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diabetic Retinopathy (DR) Analysis Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diabetic Retinopathy (DR) Analysis Software Market Report

Report Metric	Details
Report Name	Diabetic Retinopathy (DR) Analysis Software Market
Accounted market size in 2023	US$ 1207 million
Forecasted market size in 2030	US$ 2045.2 million
CAGR	7.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	AI Screening System AI Analysis (Disease Assessment)
Segment by Application	Clinical Diagnoses Personal Triage Investigational Use
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Evolucare, IDx Technologies Inc., Yingtong, Vistel, MONA, Eyenuk, Google Health, Optos, Zeiss, Heidelberg Engineering, Topcon Medical Systems, RetinAI, Remidio Innovative Solutions
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy (DR) Analysis Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Diabetic Retinopathy (DR) Analysis Software Market growing?

Ans: The Diabetic Retinopathy (DR) Analysis Software Market witnessing a CAGR of 7.9% during the forecast period 2024-2030.

What is the Diabetic Retinopathy (DR) Analysis Software Market size in 2030?

Ans: The Diabetic Retinopathy (DR) Analysis Software Market size in 2030 will be US$ 2045.2 million.

Who are the main players in the Diabetic Retinopathy (DR) Analysis Software Market report?

Ans: The main players in the Diabetic Retinopathy (DR) Analysis Software Market are Evolucare, IDx Technologies Inc., Yingtong, Vistel, MONA, Eyenuk, Google Health, Optos, Zeiss, Heidelberg Engineering, Topcon Medical Systems, RetinAI, Remidio Innovative Solutions

What are the Application segmentation covered in the Diabetic Retinopathy (DR) Analysis Software Market report?

Ans: The Applications covered in the Diabetic Retinopathy (DR) Analysis Software Market report are Clinical Diagnoses, Personal Triage, Investigational Use

What are the Type segmentation covered in the Diabetic Retinopathy (DR) Analysis Software Market report?

Ans: The Types covered in the Diabetic Retinopathy (DR) Analysis Software Market report are AI Screening System, AI Analysis (Disease Assessment)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 AI Screening System

1.2.3 AI Analysis (Disease Assessment)

1.3 Market by Application

1.3.1 Global Diabetic Retinopathy (DR) Analysis Software Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Diagnoses

1.3.3 Personal Triage

1.3.4 Investigational Use

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Perspective (2019-2030)

2.2 Diabetic Retinopathy (DR) Analysis Software Growth Trends by Region

2.2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Region (2019-2024)

2.2.3 Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Region (2025-2030)

2.3 Diabetic Retinopathy (DR) Analysis Software Market Dynamics

2.3.1 Diabetic Retinopathy (DR) Analysis Software Industry Trends

2.3.2 Diabetic Retinopathy (DR) Analysis Software Market Drivers

2.3.3 Diabetic Retinopathy (DR) Analysis Software Market Challenges

2.3.4 Diabetic Retinopathy (DR) Analysis Software Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diabetic Retinopathy (DR) Analysis Software Players by Revenue

3.1.1 Global Top Diabetic Retinopathy (DR) Analysis Software Players by Revenue (2019-2024)

3.1.2 Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Players (2019-2024)

3.2 Global Diabetic Retinopathy (DR) Analysis Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Diabetic Retinopathy (DR) Analysis Software Revenue

3.4 Global Diabetic Retinopathy (DR) Analysis Software Market Concentration Ratio

3.4.1 Global Diabetic Retinopathy (DR) Analysis Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy (DR) Analysis Software Revenue in 2023

3.5 Diabetic Retinopathy (DR) Analysis Software Key Players Head office and Area Served

3.6 Key Players Diabetic Retinopathy (DR) Analysis Software Product Solution and Service

3.7 Date of Enter into Diabetic Retinopathy (DR) Analysis Software Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Type

4.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Type (2019-2024)

4.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Type (2025-2030)

5 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Application

5.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Application (2019-2024)

5.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)

6.2 North America Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024)

6.4 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)

7.2 Europe Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024)

7.4 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)

8.2 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2019-2024)

8.4 Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)

9.2 Latin America Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024)

9.4 Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size (2019-2030)

10.2 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024)

10.4 Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Evolucare

11.1.1 Evolucare Company Detail

11.1.2 Evolucare Business Overview

11.1.3 Evolucare Diabetic Retinopathy (DR) Analysis Software Introduction

11.1.4 Evolucare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.1.5 Evolucare Recent Development

11.2 IDx Technologies Inc.

11.2.1 IDx Technologies Inc. Company Detail

11.2.2 IDx Technologies Inc. Business Overview

11.2.3 IDx Technologies Inc. Diabetic Retinopathy (DR) Analysis Software Introduction

11.2.4 IDx Technologies Inc. Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.2.5 IDx Technologies Inc. Recent Development

11.3 Yingtong

11.3.1 Yingtong Company Detail

11.3.2 Yingtong Business Overview

11.3.3 Yingtong Diabetic Retinopathy (DR) Analysis Software Introduction

11.3.4 Yingtong Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.3.5 Yingtong Recent Development

11.4 Vistel

11.4.1 Vistel Company Detail

11.4.2 Vistel Business Overview

11.4.3 Vistel Diabetic Retinopathy (DR) Analysis Software Introduction

11.4.4 Vistel Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.4.5 Vistel Recent Development

11.5 MONA

11.5.1 MONA Company Detail

11.5.2 MONA Business Overview

11.5.3 MONA Diabetic Retinopathy (DR) Analysis Software Introduction

11.5.4 MONA Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.5.5 MONA Recent Development

11.6 Eyenuk

11.6.1 Eyenuk Company Detail

11.6.2 Eyenuk Business Overview

11.6.3 Eyenuk Diabetic Retinopathy (DR) Analysis Software Introduction

11.6.4 Eyenuk Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.6.5 Eyenuk Recent Development

11.7 Google Health

11.7.1 Google Health Company Detail

11.7.2 Google Health Business Overview

11.7.3 Google Health Diabetic Retinopathy (DR) Analysis Software Introduction

11.7.4 Google Health Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.7.5 Google Health Recent Development

11.8 Optos

11.8.1 Optos Company Detail

11.8.2 Optos Business Overview

11.8.3 Optos Diabetic Retinopathy (DR) Analysis Software Introduction

11.8.4 Optos Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.8.5 Optos Recent Development

11.9 Zeiss

11.9.1 Zeiss Company Detail

11.9.2 Zeiss Business Overview

11.9.3 Zeiss Diabetic Retinopathy (DR) Analysis Software Introduction

11.9.4 Zeiss Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.9.5 Zeiss Recent Development

11.10 Heidelberg Engineering

11.10.1 Heidelberg Engineering Company Detail

11.10.2 Heidelberg Engineering Business Overview

11.10.3 Heidelberg Engineering Diabetic Retinopathy (DR) Analysis Software Introduction

11.10.4 Heidelberg Engineering Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.10.5 Heidelberg Engineering Recent Development

11.11 Topcon Medical Systems

11.11.1 Topcon Medical Systems Company Detail

11.11.2 Topcon Medical Systems Business Overview

11.11.3 Topcon Medical Systems Diabetic Retinopathy (DR) Analysis Software Introduction

11.11.4 Topcon Medical Systems Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.11.5 Topcon Medical Systems Recent Development

11.12 RetinAI

11.12.1 RetinAI Company Detail

11.12.2 RetinAI Business Overview

11.12.3 RetinAI Diabetic Retinopathy (DR) Analysis Software Introduction

11.12.4 RetinAI Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.12.5 RetinAI Recent Development

11.13 Remidio Innovative Solutions

11.13.1 Remidio Innovative Solutions Company Detail

11.13.2 Remidio Innovative Solutions Business Overview

11.13.3 Remidio Innovative Solutions Diabetic Retinopathy (DR) Analysis Software Introduction

11.13.4 Remidio Innovative Solutions Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

11.13.5 Remidio Innovative Solutions Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Evolucare

IDx Technologies Inc.

Heidelberg Engineering

Topcon Medical Systems

RetinAi

Remidio Innovative Solutions

List of Tables

Table 1. Global Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of AI Screening System

Table 3. Key Players of AI Analysis (Disease Assessment)

Table 4. Global Diabetic Retinopathy (DR) Analysis Software Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Region (2019-2024)

Table 8. Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Region (2025-2030)

Table 10. Diabetic Retinopathy (DR) Analysis Software Market Trends

Table 11. Diabetic Retinopathy (DR) Analysis Software Market Drivers

Table 12. Diabetic Retinopathy (DR) Analysis Software Market Challenges

Table 13. Diabetic Retinopathy (DR) Analysis Software Market Restraints

Table 14. Global Diabetic Retinopathy (DR) Analysis Software Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Players (2019-2024)

Table 16. Global Top Diabetic Retinopathy (DR) Analysis Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy (DR) Analysis Software as of 2023)

Table 17. Ranking of Global Top Diabetic Retinopathy (DR) Analysis Software Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Diabetic Retinopathy (DR) Analysis Software Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Diabetic Retinopathy (DR) Analysis Software Product Solution and Service

Table 21. Date of Enter into Diabetic Retinopathy (DR) Analysis Software Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Type (2019-2024)

Table 25. Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Type (2025-2030)

Table 27. Global Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Application (2019-2024)

Table 29. Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Application (2025-2030)

Table 31. North America Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2025-2030) & (US$ Million)

Table 46. Evolucare Company Detail

Table 47. Evolucare Business Overview

Table 48. Evolucare Diabetic Retinopathy (DR) Analysis Software Product

Table 49. Evolucare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 50. Evolucare Recent Development

Table 51. IDx Technologies Inc. Company Detail

Table 52. IDx Technologies Inc. Business Overview

Table 53. IDx Technologies Inc. Diabetic Retinopathy (DR) Analysis Software Product

Table 54. IDx Technologies Inc. Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 55. IDx Technologies Inc. Recent Development

Table 56. Yingtong Company Detail

Table 57. Yingtong Business Overview

Table 58. Yingtong Diabetic Retinopathy (DR) Analysis Software Product

Table 59. Yingtong Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 60. Yingtong Recent Development

Table 61. Vistel Company Detail

Table 62. Vistel Business Overview

Table 63. Vistel Diabetic Retinopathy (DR) Analysis Software Product

Table 64. Vistel Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 65. Vistel Recent Development

Table 66. MONA Company Detail

Table 67. MONA Business Overview

Table 68. MONA Diabetic Retinopathy (DR) Analysis Software Product

Table 69. MONA Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 70. MONA Recent Development

Table 71. Eyenuk Company Detail

Table 72. Eyenuk Business Overview

Table 73. Eyenuk Diabetic Retinopathy (DR) Analysis Software Product

Table 74. Eyenuk Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 75. Eyenuk Recent Development

Table 76. Google Health Company Detail

Table 77. Google Health Business Overview

Table 78. Google Health Diabetic Retinopathy (DR) Analysis Software Product

Table 79. Google Health Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 80. Google Health Recent Development

Table 81. Optos Company Detail

Table 82. Optos Business Overview

Table 83. Optos Diabetic Retinopathy (DR) Analysis Software Product

Table 84. Optos Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 85. Optos Recent Development

Table 86. Zeiss Company Detail

Table 87. Zeiss Business Overview

Table 88. Zeiss Diabetic Retinopathy (DR) Analysis Software Product

Table 89. Zeiss Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 90. Zeiss Recent Development

Table 91. Heidelberg Engineering Company Detail

Table 92. Heidelberg Engineering Business Overview

Table 93. Heidelberg Engineering Diabetic Retinopathy (DR) Analysis Software Product

Table 94. Heidelberg Engineering Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 95. Heidelberg Engineering Recent Development

Table 96. Topcon Medical Systems Company Detail

Table 97. Topcon Medical Systems Business Overview

Table 98. Topcon Medical Systems Diabetic Retinopathy (DR) Analysis Software Product

Table 99. Topcon Medical Systems Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 100. Topcon Medical Systems Recent Development

Table 101. RetinAI Company Detail

Table 102. RetinAI Business Overview

Table 103. RetinAI Diabetic Retinopathy (DR) Analysis Software Product

Table 104. RetinAI Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 105. RetinAI Recent Development

Table 106. Remidio Innovative Solutions Company Detail

Table 107. Remidio Innovative Solutions Business Overview

Table 108. Remidio Innovative Solutions Diabetic Retinopathy (DR) Analysis Software Product

Table 109. Remidio Innovative Solutions Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024) & (US$ Million)

Table 110. Remidio Innovative Solutions Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Diabetic Retinopathy (DR) Analysis Software Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Type: 2023 VS 2030

Figure 3. AI Screening System Features

Figure 4. AI Analysis (Disease Assessment) Features

Figure 5. Global Diabetic Retinopathy (DR) Analysis Software Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Application: 2023 VS 2030

Figure 7. Clinical Diagnoses Case Studies

Figure 8. Personal Triage Case Studies

Figure 9. Investigational Use Case Studies

Figure 10. Diabetic Retinopathy (DR) Analysis Software Report Years Considered

Figure 11. Global Diabetic Retinopathy (DR) Analysis Software Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Diabetic Retinopathy (DR) Analysis Software Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Region: 2023 VS 2030

Figure 14. Global Diabetic Retinopathy (DR) Analysis Software Market Share by Players in 2023

Figure 15. Global Top Diabetic Retinopathy (DR) Analysis Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy (DR) Analysis Software as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Diabetic Retinopathy (DR) Analysis Software Revenue in 2023

Figure 17. North America Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2019-2030)

Figure 19. United States Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2019-2030)

Figure 23. Germany Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Diabetic Retinopathy (DR) Analysis Software Market Share by Region (2019-2030)

Figure 31. China Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2019-2030)

Figure 39. Mexico Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Diabetic Retinopathy (DR) Analysis Software Market Share by Country (2019-2030)

Figure 43. Turkey Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Diabetic Retinopathy (DR) Analysis Software Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Evolucare Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 46. IDx Technologies Inc. Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 47. Yingtong Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 48. Vistel Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 49. MONA Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 50. Eyenuk Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 51. Google Health Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 52. Optos Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 53. Zeiss Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 54. Heidelberg Engineering Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 55. Topcon Medical Systems Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 56. RetinAI Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 57. Remidio Innovative Solutions Revenue Growth Rate in Diabetic Retinopathy (DR) Analysis Software Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions